EN
HI
Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
5.02 L
Market Cap
11448.32 CR
LTQ@LTP
9@300.35
ATP
298.43
Var Margin
35 %
Circuit Range
239.4-359.1
Delivery %
58.42 %
Value
14.97 CR
ASM/GSM
No
Market Lot
1
Summary
At 23 Mar, 2026 | 14:20, Cohance Lifesciences share price stands at ₹300.35, showing a 1.10% 0.37 for the day. The stock’s intraday movement has stayed between ₹292.70 and ₹302.40, while on a 52-week basis it has fluctuated from ₹266.70 to ₹1250.00.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 501773 shares, with a market capitalisation of ₹382567140. The stock’s Average Traded Price (ATP) stands at ₹29843, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9,30035. The stock operates within a circuit range of ₹239.4-359.1, with a Value of ₹14.97 CR. The Delivery Percentage for the day is 58.42%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
View MoreP/E Ratio
56.76
P/B Ratio
3
Div. Yield
0
Sector P/E
60
Sector P/B
2.64
Sec. Div. Yield
0.59
Cohance Lifesciences Resistance and Support
Pivot 299.85
Resistance
First Resistance
303.65
Second Resistance
308.05
Third Resistance
311.85
Support
First Support
295.45
Second Support
291.65
Third Support
287.25
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Cohance Lifesciences reported an inter-se transfer of 7.7 million shares (2.01% equity) between Jasti Property and Equity Holdings Private Limited and Jasub Property Holdings LLP on February 23, 2026. This transaction, executed via block deals, resulted in a corresponding decrease and increase in their respective holdings.
Feb 24 2026 17:02:00
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Mr. Vivek Sharma | Executive Chairman |
| Dr. V Prasada Raju | Managing Director |
Cohance Lifesciences Similar Stocks
Alembic Pharmaceuticals Ltd.
642.20
-35.10 (5.18%)
Jubilant Pharmova Ltd.
818.50
-12.85 (1.55%)
Poly Medicure Ltd.
1227.80
-13.10 (1.06%)
Alivus Life Sciences Ltd.
934.45
-15.35 (1.62%)
Caplin Point Laboratories Ltd.
1563.00
-41.10 (2.56%)
Concord Biotech Ltd.
1049.90
-42.40 (3.88%)
Rainbow Children's Medicare Ltd.
1102.00
-12.30 (1.10%)
Sanofi Consumer Healthcare India Ltd.
4075.80
-176.20 (4.14%)
CORONA Remedies Ltd.
1594.70
-55.80 (3.38%)
Metropolis Healthcare Ltd.
430.00
-11.10 (2.52%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 300.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 56.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 3. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 60 & 2.64 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 11448.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1250.00 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
